par Mayer, Erica L;Baurain, Jean-Francois;Sparano, Joseph;Strauss, Lewis;Campone, Mario;Fumoleau, Pierre;Rugo, Hope;Awada, Ahmad ;Sy, Oumar;Llombart-Cussac, Antonio
Référence Clinical cancer research, 17, 21, page (6897-6904)
Publication Publié, 2011-11
Référence Clinical cancer research, 17, 21, page (6897-6904)
Publication Publié, 2011-11
Article révisé par les pairs
Titre: |
|
Auteur: | Mayer, Erica L; Baurain, Jean-Francois; Sparano, Joseph; Strauss, Lewis; Campone, Mario; Fumoleau, Pierre; Rugo, Hope; Awada, Ahmad; Sy, Oumar; Llombart-Cussac, Antonio |
Informations sur la publication: | Clinical cancer research, 17, 21, page (6897-6904) |
Statut de publication: | Publié, 2011-11 |
Sujet CREF: | Cancérologie |
MeSH keywords: | Administration, Oral |
Adult | |
Aged | |
Breast Neoplasms -- drug therapy -- metabolism | |
Female | |
Humans | |
Middle Aged | |
Protein Kinase Inhibitors -- adverse effects -- therapeutic use | |
Pyrimidines -- adverse effects -- therapeutic use | |
Receptor, erbB-2 -- biosynthesis | |
Receptors, Estrogen -- biosynthesis | |
Receptors, Progesterone -- biosynthesis | |
Thiazoles -- adverse effects -- therapeutic use | |
src-Family Kinases -- antagonists & inhibitors -- metabolism | |
Note générale: | Clinical Trial, Phase II |
Journal Article | |
Research Support, Non-U.S. Gov't | |
SCOPUS: ar.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:1078-0432 |
info:doi/10.1158/1078-0432.CCR-11-0070 | |
info:pii/1078-0432.CCR-11-0070 | |
info:scp/80455132309 | |
info:pmid/21903773 |